Erratum: Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9® lead to promotion versus suppression of prostate cancer metastasis (J. Biol. Chem. (2013) 288 (19359-19369) DOI: 10.1074/jbc.M113.477216)

Tzu Hua Lin; Soo Ok Lee; Yuanjie Niu; Defeng Xu; Liang Liang; Lei Li; Shauh Der Yeh; Naohiro Fujimoto; Shuyuan Yeh; Chawnshang Chang

doi:10.1074/jbc.AAC120.016502

Erratum: Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9^® lead to promotion versus suppression of prostate cancer metastasis (J. Biol. Chem. (2013) 288 (19359-19369) DOI: 10.1074/jbc.M113.477216)

Tzu Hua Lin
, Soo Ok Lee
, Yuanjie Niu
, Defeng Xu
, Liang Liang
, Lei Li
, Shauh Der Yeh
, Naohiro Fujimoto
, Shuyuan Yeh
, Chawnshang Chang

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

For Fig. 5E, in the last row stained for PSA, one of the images in the MDV group was mistakenly inserted as the ASC group with a vertical translation during article preparation. The correct images from the MDV group and ASC group are presented in the corrected figure. We sincerely apologize for the error, and we assure that the correction of the images will not alter the original results or conclusions.

Original language	English
Pages (from-to)	15796
Number of pages	1
Journal	Journal of Biological Chemistry
Volume	295
Issue number	46
DOIs	https://doi.org/10.1074/jbc.AAC120.016502
Publication status	Published - Nov 13 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Biochemistry
Molecular Biology
Cell Biology

Access to Document

10.1074/jbc.AAC120.016502

Fingerprint

Dive into the research topics of 'Erratum: Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9^® lead to promotion versus suppression of prostate cancer metastasis (J. Biol. Chem. (2013) 288 (19359-19369) DOI: 10.1074/jbc.M113.477216)'. Together they form a unique fingerprint.

Cite this

Lin, T. H., Lee, S. O., Niu, Y., Xu, D., Liang, L., Li, L., Yeh, S. D., Fujimoto, N., Yeh, S., & Chang, C. (2020). Erratum: Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9^® lead to promotion versus suppression of prostate cancer metastasis (J. Biol. Chem. (2013) 288 (19359-19369) DOI: 10.1074/jbc.M113.477216). Journal of Biological Chemistry, 295(46), 15796. https://doi.org/10.1074/jbc.AAC120.016502

Erratum: Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9^® lead to promotion versus suppression of prostate cancer metastasis (J. Biol. Chem. (2013) 288 (19359-19369) DOI: 10.1074/jbc.M113.477216). / Lin, Tzu Hua; Lee, Soo Ok; Niu, Yuanjie et al.
In: Journal of Biological Chemistry, Vol. 295, No. 46, 13.11.2020, p. 15796.

Research output: Contribution to journal › Comment/debate › peer-review

Lin, TH, Lee, SO, Niu, Y, Xu, D, Liang, L, Li, L, Yeh, SD, Fujimoto, N, Yeh, S & Chang, C 2020, 'Erratum: Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9^® lead to promotion versus suppression of prostate cancer metastasis (J. Biol. Chem. (2013) 288 (19359-19369) DOI: 10.1074/jbc.M113.477216)', Journal of Biological Chemistry, vol. 295, no. 46, pp. 15796. https://doi.org/10.1074/jbc.AAC120.016502

Lin TH, Lee SO, Niu Y, Xu D, Liang L, Li L et al. Erratum: Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9^® lead to promotion versus suppression of prostate cancer metastasis (J. Biol. Chem. (2013) 288 (19359-19369) DOI: 10.1074/jbc.M113.477216). Journal of Biological Chemistry. 2020 Nov 13;295(46):15796. doi: 10.1074/jbc.AAC120.016502

Lin, Tzu Hua ; Lee, Soo Ok ; Niu, Yuanjie et al. / Erratum : Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9^® lead to promotion versus suppression of prostate cancer metastasis (J. Biol. Chem. (2013) 288 (19359-19369) DOI: 10.1074/jbc.M113.477216). In: Journal of Biological Chemistry. 2020 ; Vol. 295, No. 46. pp. 15796.

@article{0123368ab8e4415da602fe736deef2cf,

title = "Erratum: Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9{\textregistered} lead to promotion versus suppression of prostate cancer metastasis (J. Biol. Chem. (2013) 288 (19359-19369) DOI: 10.1074/jbc.M113.477216)",

abstract = "For Fig. 5E, in the last row stained for PSA, one of the images in the MDV group was mistakenly inserted as the ASC group with a vertical translation during article preparation. The correct images from the MDV group and ASC group are presented in the corrected figure. We sincerely apologize for the error, and we assure that the correction of the images will not alter the original results or conclusions.",

author = "Lin, \{Tzu Hua\} and Lee, \{Soo Ok\} and Yuanjie Niu and Defeng Xu and Liang Liang and Lei Li and Yeh, \{Shauh Der\} and Naohiro Fujimoto and Shuyuan Yeh and Chawnshang Chang",

note = "Publisher Copyright: {\textcopyright} 2020 by The American Society for Biochemistry and Molecular Biology, Inc.",

year = "2020",

month = nov,

day = "13",

doi = "10.1074/jbc.AAC120.016502",

language = "English",

volume = "295",

pages = "15796",

journal = "Journal of Biological Chemistry",

issn = "0021-9258",

publisher = "American Society for Biochemistry and Molecular Biology Inc.",

number = "46",

}

TY - JOUR

T1 - Erratum

T2 - Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9® lead to promotion versus suppression of prostate cancer metastasis (J. Biol. Chem. (2013) 288 (19359-19369) DOI: 10.1074/jbc.M113.477216)

AU - Lin, Tzu Hua

AU - Lee, Soo Ok

AU - Niu, Yuanjie

AU - Xu, Defeng

AU - Liang, Liang

AU - Li, Lei

AU - Yeh, Shauh Der

AU - Fujimoto, Naohiro

AU - Yeh, Shuyuan

AU - Chang, Chawnshang

PY - 2020/11/13

Y1 - 2020/11/13

N2 - For Fig. 5E, in the last row stained for PSA, one of the images in the MDV group was mistakenly inserted as the ASC group with a vertical translation during article preparation. The correct images from the MDV group and ASC group are presented in the corrected figure. We sincerely apologize for the error, and we assure that the correction of the images will not alter the original results or conclusions.

AB - For Fig. 5E, in the last row stained for PSA, one of the images in the MDV group was mistakenly inserted as the ASC group with a vertical translation during article preparation. The correct images from the MDV group and ASC group are presented in the corrected figure. We sincerely apologize for the error, and we assure that the correction of the images will not alter the original results or conclusions.

UR - https://www.scopus.com/pages/publications/85096154691

UR - https://www.scopus.com/pages/publications/85096154691#tab=citedBy

U2 - 10.1074/jbc.AAC120.016502

DO - 10.1074/jbc.AAC120.016502

M3 - Comment/debate

C2 - 33188084

AN - SCOPUS:85096154691

SN - 0021-9258

VL - 295

SP - 15796

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

IS - 46

ER -